Glucagon-like peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the National Institutes of Health all of U.S
Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
We offer this innovative treatment to help patients achieve their weight loss goals alongside better blood sugar control
I had a really great experience at Blue Alchemy IV
High sensitivity ensures reliable measurement of low-abundance proteins, hormones, or antibodies, which is essential for early disease detection and research applications
18 Diagnostic tools The Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale is a simple tool to further characterize a patients complaints and narrow the DDx
